Healthcare
UnitedHealth Group Incorporated (UNH)
Data as of July 7, 2026
Environment story
Source documents (10-K risk factors, 2026 proxy) contain no dedicated environmental/sustainability disclosures, Scope 1/2/3 emissions data, renewable energy percentages, or a stated net-zero target year. Under the deterministic rubric, undisclosed Scope 3 data and absence of a qualifying net-zero commitment before 2045 each trigger standard deductions. No specific toxic-waste or water-consumption controversies were identified in the provided filings. This is a research finding, not investment guidance.
Criticisms on file
No material criticisms on file for this pillar.
Disclosed initiatives
No disclosed initiatives on file for this pillar.
Social story
The provided 10-K and proxy statement do not disclose CEO-to-median-worker pay ratio figures, workforce diversity percentages, turnover rates, or union relationship details, despite the proxy referencing a 'CEO Pay Ratio' section by page number. No documented strikes, NLRB actions, or union-suppression allegations appear in the source materials. Absent verifiable adverse facts, no rubric deductions were applied to this pillar based on the documents supplied. This is a research finding, not investment guidance.
Criticisms on file
No material criticisms on file for this pillar.
Disclosed initiatives
No disclosed initiatives on file for this pillar.
Governance story
UnitedHealth Group maintains a single-class share structure and a board composed predominantly of independent directors (8 of 9 nominees, with CEO Stephen Hemsley as the sole non-independent nominee), exceeding the 75% independence threshold. However, the 10-K discloses recurring exposure to antitrust enforcement actions, False Claims Act whistleblower litigation, CMS RADV audit recoupments, PBM practice investigations, and a disclosed 2024 Change Healthcare cyberattack involving protected health information — collectively warranting a deduction for active regulatory/legal proceedings. No dual-class structure or shareholder-litigation-to-block-climate-proposals pattern was identified. This is a research finding, not investment guidance.
Criticisms on file
-
Exposure to antitrust regulatory enforcement actions, including past actions brought against the Company affecting its ability to complete strategic transactions.Source: UNH_10k.txt - Risk Factors, 'strategic alliances...acquisitions' section
-
Whistleblower and False Claims Act litigation risk related to alleged submission of false or erroneous claims to government payers.Source: UNH_10k.txt - Risk Factors, 'routinely subject to private party and governmental legal actions' section
-
Governmental investigations into pharmacy benefit manager (PBM) practices at Optum Rx, which have resulted in civil penalties and corporate integrity agreements industry-wide.Source: UNH_10k.txt - Risk Factors, 'pharmacy care services businesses' section
-
2024 cyberattack on the recently-acquired Change Healthcare business resulting in exposure of protected health information/personally identifiable information.Source: UNH_10k.txt - Risk Factors, 'cyberattacks or other privacy or data security incidents' section
-
CMS Risk Adjustment Data Validation (RADV) audits of selected Medicare Advantage plans, which have resulted in retrospective payment adjustments, fines, and corrective action plans.Source: UNH_10k.txt - Risk Factors, government health care programs section
Disclosed initiatives
-
AI Governance OversightAudit and Finance Committee oversees the Company's artificial intelligence framework, including governance mechanisms to monitor, identify, and mitigate risks associated with AI deployment.Establishes board-level risk oversight structure for AI-related operational and compliance risk.
-
Shareholder Engagement Following 2025 Say-on-Pay VoteCompany contacted 46 shareholders representing 60% of outstanding shares (including 12 who voted against 2025 Say-on-Pay) and held discussions with 21 shareholders (51% of shares); adopted policy changes including elimination of front-loaded stock awards and added retention requirements on CEO option grants.Demonstrates responsiveness to shareholder feedback on executive compensation practices.
These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of UnitedHealth Group Incorporated. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open UnitedHealth Group Incorporated in the app for interactive charts and portfolio building.
Browse Companies · Methodology · Terms of Service · Privacy Policy · Back to Missionomics